As of May 12, 2025, Oaktree Acquisition Corp. III Life Sciences Unit has 200 shares failed to deliver, representing 76.63% of the average daily volume of 261 shares. Over the past year, the monthly average FTD is 5,191 shares, with the current level 96% below the historical average, indicating low settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.